Condition 1: Iron deficiency anaemia. Condition 2: Iron deficiency anaemia. Iron deficiency anaemia, unspecified Other iron deficiency anaemias
Conditions
Interventions
Intervention 1: Group or the control pf: People with iron-deficiency anemia that is based on sharing a random day a number of placebo capsules containing 500 mg of corn oil + a tablet of sulfate conta
Placebo
Treatment - Drugs
Sponsors
Tehran University of Medical Sciences and Health services
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: • Hemoglobin> g / dl 12, HCT <35% and transferrin saturation less than 15% • Women in the range of 15 to 45 years of age • regular menstrual cycles • willingness to cooperate and fill the criteria of informed consent form to the project exclusion criteria: • smoking tobacco or alcohol • iron supplements, multivitamins and antioxidants in the last three months • the use of lipid-lowering drugs, oral contraceptives • the use of oral contraceptives • parasitic infections (those who have been diagnosed positive stool test will be excluded.) • thalassemia disease • kidney disease, liver disease, diabetes • local or systemic infection or inflammatory disease • history of ulcer disease or gastrointestinal bleeding or fibroids •malabsorption such as celiac sprue or steatorrhea • Any type of blood transfusion in the last 2 months of • pregnancy or lactation • not wanting to continue working • inadequate compliance supplement (compliance less than 80%) • change in diet or physical activity for any reason
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Catalase. Timepoint: before the experiment.12 weeks after intervention. Method of measurement: by k/gHb spectrophotometry.;Malondialdehyde. Timepoint: before the experiment.12 weeks after intervention. Method of measurement: by Nmol/ml theobarbituryk acid method.;Triglycerides. Timepoint: before the experiment.12 weeks after intervention. Method of measurement: by Mg/dl colorimetric method.;High density lipoprotein. Timepoint: before the experiment.12 weeks after intervention. Method of measurement: by Mg/dl enzymetic method.;Blood hemoglobin. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: Based on Mg / dl using cell counter machine.;Fasting serum iron. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: According ? g / dl spectrophotometry.;Total iron binding capacity. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: According ? g / dl spectrophotometry.;Mean corpuscular volume. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: based on (Fl) calculated by the formula.;Mean Corpuscular Hemoglobin Concentration. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: based on (g/dl) calculated by the formula.;Hematocrit. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: Percent to the cell counter.;Transferrin saturation. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: Based on the percentage determined by the formula. | — |
Secondary
| Measure | Time frame |
|---|---|
| Selenium. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: Terms (mg/day) over a 24-hour dietary questionnaire.;Copper. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: Terms (mg/day) over a 24-hour dietary questionnaire.;Sodium. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: Terms (mg/day) over a 24-hour dietary questionnaire.;Potassium. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: Terms (mg/day) over a 24-hour dietary questionnaire.;Kind of fat. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: Terms (mg/day) over a 24-hour dietary questionnaire.;Level of physical activity. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: In terms of intensity (light, medium and heavy) information through a questionnaire.;Betacarotene. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: Terms (mg/day) over a 24-hour dietary questionnaire.;Iron. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: Terms (mg/day) over a 24-hour dietary questionnaire.;Zinc. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: Terms (mg/day) over a 24-hour dietary questionnaire.;Body mass index. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: Kg/m2 calculated based on the height and weight.;Age. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: In terms of the question.;Energy intake. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: Terms (kcal / day) over a 24-hour dietary questionnaire.;Carbohydrate intake. Timepoint: Before the experiment, 12 weeks after intervention. Method of measurement: Terms (g/day) over a 24-hour dietary questionnaire.;Protein intake. Tim | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSamira Amani
Tehran University of Medical Therapy
Outcome results
None listed